Antares Pharma Announces Positive Results from the VIBEX QuickShot Pharmacokinetic Study in Testosterone Deficient Men

[Business Wire] – Antares Pharma, Inc. today announced positive results from a multi-center phase 2 clinical study evaluating the pharmacokinetic profile of testosterone enanthate adm more

View todays social media effects on ATRS

View the latest stocks trending across Twitter. Click to view dashboard

See who Antares is hiring next, click here to view